12:46 PM
 | 
Jan 09, 2019
 |  BC Extra  |  Politics & Policy

House bill would push Part D price negotiations

A bipartisan bill introduced in Congress Tuesday aims to force the Trump administration's hand on Medicare Part D price negotiations, and would require HHS to bargain directly with drugmakers.

HHS Secretary Alex Azar has previously rejected the approach, which is not included in the administration’s 2018 drug pricing blueprint. The administration called for controlling Part D costs by creating a cap on Part D out-of-pocket spending (see "Trump Will Not Propose Medicare Part D Negotiation").

Pricing negotiations by HHS are prohibited under Part D.

The bill was introduced by Reps. Peter Welch (D-Vt.) and Francis Rooney (R-Fla.) and co-sponsored by nine other House Democrats.

Welch co-sponsored a similar bill in 2017 exclusively with fellow Democrats such as Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.), who will announce a package of co-sponsored bills addressing drug pricing on Thursday (see "Drug Price Negotiation Bill Introduced").

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD